Haleon, a global leader in consumer health, today announced the appointment of Christine Jakovcic as General Manager, Haleon ...

Pfizer has offloaded a £2.43billion stake in consumer health spin-out Haleon, which said it would buy back £230million of the ...

Pfizer has divested a $3.3 billion stake in Haleon, reducing its holding in the British consumer healthcare company.

Haleon was formed in 2019 by the merger of the consumer healthcare businesses of GSK and US rival Pfizer, but was spun out ...

Pfizer, a New York-based pharmaceuticals firm, sold 640 million Haleon shares at 380 pence per share in a placing run by Goldman Sachs International and BofA Securities as joint global coordinators.

Pfizer has sold a stake in British consumer healthcare group Haleon worth about $3.26 billion, cutting its shareholding in ...

Investment bank Peel Hunt today said market activity has slowed in recent weeks ahead of the upcoming Budget and US ...

Greggs has indicated an easing of cost inflation as it made "further good progress" in the third quarter. Plus, the BRC ...

The Australian pilots union said on Tuesday that it has rejected a wage proposal from Qantas Airways for its short haul ...

From US drugmaker Pfizer's stake sale in Sensodyne maker Haleon to Beijing joining the list of Chinese cities easing ...

On completion, Pfizer, the New York-based pharmaceuticals firm, will see its interest in Haleon fall to just over 16% from 22.6% currently. Bloomberg reported that the share sale price is likely to be ...